Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2016 Jun 22;6:29056. doi: 10.1038/srep29056

Retraction: Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties

Nima Samie, Sekaran Muniandy, M S Kanthimathi, Batoul Sadat Haerian, Raja Elina Raja Azudin
PMCID: PMC4916487  PMID: 27328968

Scientific Reports 6: Article number: 2417210.1038/srep24172; published online: April132016; updated: June222016

This Article has been retracted by the Editors and Publishers of Scientific Reports. Following online criticisms of the published paper, an investigation at the journal has confirmed the manipulation and duplication of data and a level of image processing that is not compliant with the journal’s policies on image data integrity in figures 1–3, 6, 7, 10 and 12. Versions of figures 1–11 and large sections of the text had also previously been published1,2.

All authors acknowledge these issues and agree to the retraction of the Article.

References

  1. Samie N. et al. Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells. Front. Pharmacol. 6, 313 (2016). 10.3389/fphar.2015.00313 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  2. Samie N., Muniandy S., Kanthimathi M. S. & Haerian B. S. Mechanism of action of novel piperazine containing a toxicant against human liver cancer cells. PeerJ 4, e1588 (2016). 10.7717/peerj.1588 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES